Kengo Tanabe

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto et al. · JAMA · 2019 · 801 citations · Full text

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

David E. Kandzari, Michael Böhm, Felix Mahfoud et al. · The Lancet · 2018 · 750 citations

Hypertension, Urology, Renal Function +10

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Raymond R. Townsend, Felix Mahfoud, David E. Kandzari et al. · The Lancet · 2017 · 718 citations

Hypertension, Urology, Renal Function +10

Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”

Pedro A. Lemos, Patrick W. Serruys, Ron T. van Domburg et al. · Circulation · 2003 · 543 citations · Full text

Intravascular Ultrasound Findings in the Multicenter, Randomized, Double-Blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) Trial

Patrick W. Serruys, Muzaffer Değertekin, Kengo Tanabe et al. · Circulation · 2002 · 354 citations · Full text